Company intelligence / Profile preview

Meso Scale Diagnostics

Rockville, Maryland, United Statesmesoscale.com ↗

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

Meso Scale Diagnostics’ MULTI‑ARRAY technology has been widely adopted by pharmaceutical companies, academic institutions, government labs, and clinical laboratories worldwide. The company received its first FDA 510(k) clearance for an in vitro diagnostic assay measuring C-reactive protein in 2018. Their platform enables high-sensitivity multiplexed detection of biomarkers with applications ranging from basic research to clinical diagnostics[8].

Therapeutic areas: OncologyImmunologyNeurologyInfectious Diseases
Modalities: Assay platformImmunoassaysElectrochemiluminescence Detection
Industry: Protein Biomarker Diagnostics

Partnerships

IGEN International (licensing relationships)Roche (litigation/technology overlap)BioVeris (litigation/technology overlap)

Beyond the preview

Go deeper on Meso Scale Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meso Scale Diagnostics.

Explore the full profile